RDHL

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Redhill Biopharma Ltd

NASDAQ | RDHL

1.73

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 20, 2025)

$4.99M

Market Cap

0

P/E Ratio

0

EPS

$8.90

52 Week High

$1.06

52 Week Low

HEALTHCARE

Sector

RDHL Chart

Recent Chart
Price Action

RDHL Technicals

Tags:

RDHL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $4.9M
Total Revenue $8M
Cost Of Revenue $3.2M
Costof Goods And Services Sold $3.2M
Operating Income -$15M
Selling General And Administrative $15M
Research And Development $1.6M
Operating Expenses $19M
Investment Income Net -
Net Interest Income -$1.9M
Interest Income $133K
Interest Expense $55K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $619K
Income Before Tax -$8.3M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$8.3M
Comprehensive Income Net Of Tax -
Ebit -$8.2M
Ebitda -$7.6M
Net Income -$8.3M

Revenue & Profitability

Earnings Performance

RDHL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $18M
Total Current Assets $12M
Cash And Cash Equivalents At Carrying Value $4.6M
Cash And Short Term Investments $4.6M
Inventory $3.7M
Current Net Receivables $3.6M
Total Non Current Assets $6.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $5.5M
Intangible Assets Excluding Goodwill $5.5M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $2.7M
Other Current Assets $77K
Other Non Current Assets -
Total Liabilities $23M
Total Current Liabilities $22M
Current Accounts Payable $7.9M
Deferred Revenue -
Current Debt -
Short Term Debt $706K
Total Non Current Liabilities $503K
Capital Lease Obligations $356K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $356K
Other Current Liabilities $14M
Other Non Current Liabilities $500K
Total Shareholder Equity -$4.7M
Treasury Stock -
Retained Earnings -$415M
Common Stock $35M
Common Stock Shares Outstanding $2.5M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$9.4M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $619K
Capital Expenditures $9K
Change In Receivables -
Change In Inventory $738K
Profit Loss -
Cashflow From Investment -$9K
Cashflow From Financing $8.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$8.3M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $4.9M
Total Revenue $8M
Cost Of Revenue $3.2M
Costof Goods And Services Sold $3.2M
Operating Income -$15M
Selling General And Administrative $15M
Research And Development $1.6M
Operating Expenses $19M
Investment Income Net -
Net Interest Income -$1.9M
Interest Income $133K
Interest Expense $55K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $619K
Income Before Tax -$8.3M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$8.3M
Comprehensive Income Net Of Tax -
Ebit -$8.2M
Ebitda -$7.6M
Net Income -$8.3M

RDHL News

RDHL Profile

Redhill Biopharma Ltd Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

RedHill Biopharma Ltd. (RDHL) is a Tel Aviv-based specialty biopharmaceutical company focused on developing and commercializing innovative therapeutic solutions primarily for gastrointestinal and infectious diseases. The company boasts a promising pipeline that features proprietary products alongside strategic partnerships, aimed at addressing substantial unmet medical needs. Leveraging its advanced clinical research capabilities and regulatory expertise, RedHill is strategically positioned to enhance patient outcomes and solidify its role as a significant player in the biopharmaceutical sector, targeting both niche and broader healthcare markets.

BYND
+127.69%
$1.47
VHAI
0.00%
$0.00
YYAI
-17.27%
$0.10
ADAP
-70.51%
$0.05
CGBS
-39.47%
$0.03
RANI
+37.19%
$2.25
YDKG
-22.28%
$0.04
CAN
+28.12%
$2.04
NVDA
-0.31%
$182.64
BITF
-0.59%
$4.98
PLUG
0.00%
$3.40
GSIT
+155.31%
$12.97
REPL
+98.77%
$8.94
AZTR
+0.39%
$0.68
NVTS
+16.64%
$17.10
GPUS
+24.21%
$0.39
AAPL
+3.94%
$262.24
BURU
-0.84%
$0.34
RXRX
+13.99%
$6.68
RGTI
-6.61%
$43.31
DVLT
+35.19%
$2.42
ACHR
+6.58%
$11.98
INTC
+2.94%
$38.10
DNN
+0.34%
$2.93
F
+0.58%
$11.99
CLF
+21.47%
$16.18
BTBT
+15.61%
$4.22
SOFI
+8.06%
$28.68
AXDX
-61.36%
$0.03
LAES
-2.84%
$6.48
T
-0.91%
$26.10
TSLA
+1.84%
$447.43
JOBY
+11.30%
$17.43
HPE
-0.39%
$22.87
AMD
+3.20%
$240.56
TLRY
+0.64%
$1.57
BTG
+2.70%
$5.70
GDXD
-7.05%
$0.67
WTO
-7.57%
$0.06
NIO
+4.59%
$7.06
RF
+2.03%
$24.06
ABAT
+38.55%
$6.72
BBD
+2.42%
$3.38
MARA
+5.92%
$20.73
RIG
+0.92%
$3.29
IONZ
+9.45%
$4.05
VIVK
+10.37%
$0.22
SMCI
+5.48%
$55.04
CLSK
+4.48%
$20.39
ETHD
-8.31%
$3.75
QBTS
-10.25%
$34.40
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
RMBL
+60.50%
$3.21
RR
+2.20%
$5.56
AAL
+2.61%
$12.17
QUBT
-5.72%
$17.28
AMZN
+1.61%
$216.48
ADD
-25.47%
$0.05
ONDS
+2.10%
$7.77
CIFR
+6.13%
$19.91
NOK
-0.52%
$5.71
PFE
+0.73%
$24.69
RIVN
+0.38%
$13.08
IREN
-2.47%
$59.22
SRM
+53.27%
$10.30
VALE
+2.70%
$11.40
DFLI
-7.35%
$1.26
USAR
+13.91%
$31.59
SOUN
+0.21%
$19.05
YGMZ
-77.05%
$0.21
ORCL
-4.85%
$277.18
PLTR
+1.93%
$181.59
UAMY
+20.01%
$13.43
BMNR
+7.92%
$53.80
GRAB
+0.53%
$5.67
HIMS
+3.17%
$51.36
KVUE
-2.15%
$14.96
CUTR
-10.19%
$0.09
ABEV
+0.88%
$2.27
PBR
+0.42%
$11.69
SNAP
+1.04%
$7.73
WLGS
-5.57%
$0.04
IONQ
-4.76%
$59.94
VZ
+0.61%
$40.79
HBAN
+2.19%
$15.84
HOOD
+4.53%
$135.80
UUUU
+7.21%
$22.58
RGTZ
+13.28%
$13.56
QS
+5.07%
$16.14
ITUB
+2.74%
$7.12
ETWO
0.00%
$3.30
CRML
-6.13%
$19.57
ASST
+3.54%
$0.86
RKLB
+1.62%
$67.34
BAC
+1.48%
$52.04
CRWV
-7.16%
$127.06
HTCR
-3.34%
$0.70
AGNC
+1.10%
$10.10
RDHL
+15.33%
$1.73
BYND
+127.69%
$1.47
VHAI
0.00%
$0.00
YYAI
-17.27%
$0.10
ADAP
-70.51%
$0.05
CGBS
-39.47%
$0.03
RANI
+37.19%
$2.25
YDKG
-22.28%
$0.04
CAN
+28.12%
$2.04
NVDA
-0.31%
$182.64
BITF
-0.59%
$4.98
PLUG
0.00%
$3.40
GSIT
+155.31%
$12.97
REPL
+98.77%
$8.94
AZTR
+0.39%
$0.68
NVTS
+16.64%
$17.10
GPUS
+24.21%
$0.39
AAPL
+3.94%
$262.24
BURU
-0.84%
$0.34
RXRX
+13.99%
$6.68
RGTI
-6.61%
$43.31
DVLT
+35.19%
$2.42
ACHR
+6.58%
$11.98
INTC
+2.94%
$38.10
DNN
+0.34%
$2.93
F
+0.58%
$11.99
CLF
+21.47%
$16.18
BTBT
+15.61%
$4.22
SOFI
+8.06%
$28.68
AXDX
-61.36%
$0.03
LAES
-2.84%
$6.48
T
-0.91%
$26.10
TSLA
+1.84%
$447.43
JOBY
+11.30%
$17.43
HPE
-0.39%
$22.87
AMD
+3.20%
$240.56
TLRY
+0.64%
$1.57
BTG
+2.70%
$5.70
GDXD
-7.05%
$0.67
WTO
-7.57%
$0.06
NIO
+4.59%
$7.06
RF
+2.03%
$24.06
ABAT
+38.55%
$6.72
BBD
+2.42%
$3.38
MARA
+5.92%
$20.73
RIG
+0.92%
$3.29
IONZ
+9.45%
$4.05
VIVK
+10.37%
$0.22
SMCI
+5.48%
$55.04
CLSK
+4.48%
$20.39
ETHD
-8.31%
$3.75
QBTS
-10.25%
$34.40
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
RMBL
+60.50%
$3.21
RR
+2.20%
$5.56
AAL
+2.61%
$12.17
QUBT
-5.72%
$17.28
AMZN
+1.61%
$216.48
ADD
-25.47%
$0.05
ONDS
+2.10%
$7.77
CIFR
+6.13%
$19.91
NOK
-0.52%
$5.71
PFE
+0.73%
$24.69
RIVN
+0.38%
$13.08
IREN
-2.47%
$59.22
SRM
+53.27%
$10.30
VALE
+2.70%
$11.40
DFLI
-7.35%
$1.26
USAR
+13.91%
$31.59
SOUN
+0.21%
$19.05
YGMZ
-77.05%
$0.21
ORCL
-4.85%
$277.18
PLTR
+1.93%
$181.59
UAMY
+20.01%
$13.43
BMNR
+7.92%
$53.80
GRAB
+0.53%
$5.67
HIMS
+3.17%
$51.36
KVUE
-2.15%
$14.96
CUTR
-10.19%
$0.09
ABEV
+0.88%
$2.27
PBR
+0.42%
$11.69
SNAP
+1.04%
$7.73
WLGS
-5.57%
$0.04
IONQ
-4.76%
$59.94
VZ
+0.61%
$40.79
HBAN
+2.19%
$15.84
HOOD
+4.53%
$135.80
UUUU
+7.21%
$22.58
RGTZ
+13.28%
$13.56
QS
+5.07%
$16.14
ITUB
+2.74%
$7.12
ETWO
0.00%
$3.30
CRML
-6.13%
$19.57
ASST
+3.54%
$0.86
RKLB
+1.62%
$67.34
BAC
+1.48%
$52.04
CRWV
-7.16%
$127.06
HTCR
-3.34%
$0.70
AGNC
+1.10%
$10.10
RDHL
+15.33%
$1.73
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.